Wen-hao Yang

No.155, Sec.2, Li Nong Street, 112
Peitou, TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Development and Ex Vivo Evaluation of a Thermoreversible Silver Nanoparticle-Loaded Gel as a Biocompatible Intracanal Medicament.

Development and Ex Vivo Evaluation of a Thermoreversible Silver Nanoparticle-Loaded Gel as a Biocompatible Intracanal Medicament.

Journal: Journal of functional biomaterials

Published: February 05, 2026

High-throughput screening system for immunogenic cell death inducers using artificial intelligence-based real-time image analysis.

High-throughput screening system for immunogenic cell death inducers using artificial intelligence-based real-time image analysis.

Journal: Computers in biology and medicine

Published: February 18, 2025

TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer.

TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer.

Journal: Clinical and experimental medicine

Published: July 01, 2024

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

Journal: American journal of cancer research

Published: June 10, 2024

Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8+ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1.

Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8+ T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 08, 2024

CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.

CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.

Journal: Molecular oncology

Published: November 17, 2023

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation.

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation.

Journal: Nature communications

Published: October 05, 2023

Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis.

Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis.

Journal: Cancer cell international

Published: April 08, 2023

Immunogenic cell death in cancer immunotherapy.

Immunogenic cell death in cancer immunotherapy.

Journal: BMB reports

Published: February 15, 2023

An undefined cystatin CsCPI1 from tea plant Camellia sinensis harbors antithrombotic activity.

An undefined cystatin CsCPI1 from tea plant Camellia sinensis harbors antithrombotic activity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 06, 2022

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.

Journal: Frontiers in immunology

Published: November 22, 2022

Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations.

Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 25, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026